KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abbott Laboratories (ABT) Interest & Investment Income (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Interest & Investment Income for 17 consecutive years, with $78.0 million as the latest value for Q4 2025.

  • Quarterly Interest & Investment Income fell 14.29% to $78.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $308.0 million through Dec 2025, down 10.47% year-over-year, with the annual reading at $308.0 million for FY2025, 10.47% down from the prior year.
  • Interest & Investment Income hit $78.0 million in Q4 2025 for Abbott Laboratories, up from $77.0 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $101.0 million in Q1 2023 to a low of $10.0 million in Q3 2021.
  • Historically, Interest & Investment Income has averaged $63.2 million across 5 years, with a median of $79.0 million in 2024.
  • Biggest five-year swings in Interest & Investment Income: tumbled 38.89% in 2021 and later soared 700.0% in 2022.
  • Year by year, Interest & Investment Income stood at $11.0 million in 2021, then skyrocketed by 700.0% to $88.0 million in 2022, then increased by 1.14% to $89.0 million in 2023, then grew by 2.25% to $91.0 million in 2024, then decreased by 14.29% to $78.0 million in 2025.
  • Business Quant data shows Interest & Investment Income for ABT at $78.0 million in Q4 2025, $77.0 million in Q3 2025, and $71.0 million in Q2 2025.